Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors.
A growing body of literature is demonstrating that Notch signaling is a more complex process than originally thought. Contradictory findings of notch-1 acting as an oncogene or a tumor suppressor revealed that its role is very specific to the cellular context. In this review we focus on the tumor suppressor role of Notch-1 signaling in neuroendocrine tumors (NETs) such as carcinoid and medullary thyroid cancers. NETs secrete various bioactive hormones that can cause debilitating symptoms. Surgery is the only potential curative treatment for the patients with NETs. Notch-1 signaling is absent in these tumors and activation of Notch-1 significantly reduces tumor growth in vitro. Therefore, identification of compound(s) that activate the Notch-1 pathway in NETs could be a potential strategy to treat patients with NETs.
Kunnimalaiyaan
Muthusamy
M
Department of Surgery, University of Wisconsin, Madison, Wisconsin 53792, USA.
Chen
Herbert
H
D000818:Animals; D002276:Carcinoid Tumor / Q000378:metabolism; D018276:Carcinoma, Medullary / Q000378:metabolism; D018288:Carcinoma, Small Cell / Q000378:metabolism; D006801:Humans; D008175:Lung Neoplasms / Q000378:metabolism; D018358:Neuroendocrine Tumors / Q000378:metabolism* / Q000503:physiopathology / Q000628:therapy; D051881:Receptor, Notch1 / Q000378:metabolism*; D015398:Signal Transduction; D025521:Tumor Suppressor Proteins / Q000378:metabolism*
C497761:NOTCH1 protein, human; D051881:Receptor, Notch1; D025521:Tumor Suppressor Proteins